AMP vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMP's deterministic health score is weak with a Piotroski F-Score of 4/9, indicating borderline financial stability. Despite strong profitability metrics like a 59.59% ROE and solid earnings growth (YoY +86.6%), the stock trades above its Graham defensive value of $235.33 at $496.60, reflecting rich valuation. Earnings volatility, declining recent estimate beats, and bearish insider activity offset strong cash flow efficiency and low leverage. Analysts concur with a 'hold' rating, aligning with technical bearishness and mixed fundamentals.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
AMP vs BRK-B: Head-to-Head Comparison
This page compares Ameriprise Financial, Inc. (AMP) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.